Compare MYSZ & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | ACON |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | MYSZ | ACON |
|---|---|---|
| Price | $0.87 | $6.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 343.5K | 61.7K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,512,000.00 | $67,483.00 |
| Revenue This Year | $29.71 | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.73 | $5.55 |
| 52 Week High | $9.40 | $3,499.49 |
| Indicator | MYSZ | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 44.73 |
| Support Level | $0.96 | $5.71 |
| Resistance Level | $0.96 | $6.89 |
| Average True Range (ATR) | 0.08 | 0.64 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 2.83 | 22.05 |
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.